Company Headquarters

UNIQUE THERAPEUTICS GLOBAL, s.r.o.
ID: 10756272
DIC: CZ10756272
Headquarters:
1559/14 Na Luhách,
Ústí nad Labem 400 01

File No.: C 46951 filed with the Regional Court in Ústí nad Labem

Bank connection

Raiffeisen Bank
CZ 1955076002/5500
IBAN: CZ35 5500 0000 0019 5507 6002
BIC (SWIFT): RZBCCZPP

Office

Radek Hlaváček

Owner, CEO

Karolína Nikoličová

Office manager

Ivana Bednářová

Marketing & Sales

Bc. Jakub Hanke

The marching representative

+420 778 476 887

jakub@greenpharmaceutics.com

Our Team

Radek Hlaváček

One of the founding members of Unique Therapeutics, a Canadian company based in Ústí nad Labem, the city where Radek lived until he was 19 years old. As an immigrant he moved to Switzerland and later to Canada, where he has lived with his wife since 1991. He started cultivating cannabis and using the flowers and extracts of Cannabis for medical purposes in 2000 after obtaining his MMAR License (Marijuana Medical Access Regulations)...1

Ivana Bednářová

vana Bednářová has twenty years of experience in sales, marketing and public relations, having held senior positions in a number of international companies during her career. Within her own marketing and PR agency, she founded and led several successful projects related to healthy lifestyle and international certification of food supplements and food. A graduate of Anglo American University with a degree in Economics, she has three children and her hobbies include sports, travel and gastronomy.

Ranjit S. Bhardwaj

Ranjit S. Bhardwaj has specialized in cellular and molecular pathology after studying biomedical sciences in the fields of immunology, immunobiology of cancer, and regenerative medicine. For over 40 years, he has been studying the role of phytomedicine in bridging ancient and modern medicine, including the manufacturing of Polyherbal Metabolite Compounds (PHMC) from medicinal cannabis and herbs. He works as a CEO, shareholder, and adviser in biotech and pharma companies, developing therapeutics for diseases such as diabetes-2 and diabetes-1, Inflammatory bowel disease (IBD), skin inflammatory indications, insomnia, and depression.

Liam Duff

As Head of Science and Technology at Unique Therapeutics, Liam is responsible for the development, testing, manufacturing and compliance of our product manufacturing processes as well as day-to-day operations. IP and technology are at the core of our company Unique Therapeutics and Liam is responsible for ensuring we stay on the cutting edge of the most effective ways to deliver cannabinoids into the body and ensuring our quality is the best it can be.